PMC:7441777 / 3560-3884
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T14","span":{"begin":56,"end":59},"obj":"Body_part"},{"id":"T15","span":{"begin":70,"end":73},"obj":"Body_part"},{"id":"T16","span":{"begin":202,"end":205},"obj":"Body_part"},{"id":"T17","span":{"begin":206,"end":212},"obj":"Body_part"}],"attributes":[{"id":"A14","pred":"fma_id","subj":"T14","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A15","pred":"fma_id","subj":"T15","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A16","pred":"fma_id","subj":"T16","obj":"http://purl.org/sig/ont/fma/fma67095"},{"id":"A17","pred":"fma_id","subj":"T17","obj":"http://purl.org/sig/ont/fma/fma84116"}],"text":" 2020).\nAnother potential drug target for SARS-CoV-2 is RNA‐dependent RNA polymerase (RdRp) (Figure 1), which is a key component of the replication machinery of the virus to make multiple copies of the RNA genome (Elfiky 2020c). RdRp in various coronaviruses are remarkably similar. For example, the RdRp of SARS-CoV exhibit"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T24","span":{"begin":42,"end":50},"obj":"Disease"},{"id":"T25","span":{"begin":308,"end":316},"obj":"Disease"}],"attributes":[{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A25","pred":"mondo_id","subj":"T25","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" 2020).\nAnother potential drug target for SARS-CoV-2 is RNA‐dependent RNA polymerase (RdRp) (Figure 1), which is a key component of the replication machinery of the virus to make multiple copies of the RNA genome (Elfiky 2020c). RdRp in various coronaviruses are remarkably similar. For example, the RdRp of SARS-CoV exhibit"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T21","span":{"begin":113,"end":114},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T22","span":{"begin":165,"end":170},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"}],"text":" 2020).\nAnother potential drug target for SARS-CoV-2 is RNA‐dependent RNA polymerase (RdRp) (Figure 1), which is a key component of the replication machinery of the virus to make multiple copies of the RNA genome (Elfiky 2020c). RdRp in various coronaviruses are remarkably similar. For example, the RdRp of SARS-CoV exhibit"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T40","span":{"begin":26,"end":30},"obj":"Chemical"}],"attributes":[{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":" 2020).\nAnother potential drug target for SARS-CoV-2 is RNA‐dependent RNA polymerase (RdRp) (Figure 1), which is a key component of the replication machinery of the virus to make multiple copies of the RNA genome (Elfiky 2020c). RdRp in various coronaviruses are remarkably similar. For example, the RdRp of SARS-CoV exhibit"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"162","span":{"begin":86,"end":90},"obj":"Gene"},{"id":"163","span":{"begin":229,"end":233},"obj":"Gene"},{"id":"172","span":{"begin":300,"end":304},"obj":"Gene"},{"id":"173","span":{"begin":42,"end":52},"obj":"Species"},{"id":"174","span":{"begin":245,"end":258},"obj":"Species"},{"id":"175","span":{"begin":308,"end":316},"obj":"Species"}],"attributes":[{"id":"A162","pred":"tao:has_database_id","subj":"162","obj":"Gene:43740578"},{"id":"A163","pred":"tao:has_database_id","subj":"163","obj":"Gene:43740578"},{"id":"A172","pred":"tao:has_database_id","subj":"172","obj":"Gene:43740578"},{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"Tax:2697049"},{"id":"A174","pred":"tao:has_database_id","subj":"174","obj":"Tax:11118"},{"id":"A175","pred":"tao:has_database_id","subj":"175","obj":"Tax:694009"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" 2020).\nAnother potential drug target for SARS-CoV-2 is RNA‐dependent RNA polymerase (RdRp) (Figure 1), which is a key component of the replication machinery of the virus to make multiple copies of the RNA genome (Elfiky 2020c). RdRp in various coronaviruses are remarkably similar. For example, the RdRp of SARS-CoV exhibit"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T33","span":{"begin":8,"end":228},"obj":"Sentence"},{"id":"T34","span":{"begin":229,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":" 2020).\nAnother potential drug target for SARS-CoV-2 is RNA‐dependent RNA polymerase (RdRp) (Figure 1), which is a key component of the replication machinery of the virus to make multiple copies of the RNA genome (Elfiky 2020c). RdRp in various coronaviruses are remarkably similar. For example, the RdRp of SARS-CoV exhibit"}